ong-term follow-up and cross-over of treatment with high-density micropulse laser and half-dose photodynamic therapy in participants of the PLACE trial for chronic central serous chorioretinopathy. - CROSS-OVER/LONG-TERM FOLLOW-UP STUDY for chronic CSC, following PLACE trial

eids Universitair Medisch Centrum0 个研究点目标入组 92 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

Trial is onging in other countries

•Only participants of the PLACE trial can be enrolled for this study.
•In the Cross-over study, the following patients will be included:
•- Subjects with persistent SRF on OCT at the final follow-up visit of the PLACE trial (7-8 months after Treatment Visit 1 PLACE trial) after either two PDT treatments in or two HSML treatments,
•- Subjects with recurrence of SRF on OCT at the final follow-up visit of the PLACE trial after one PDT or one HSML treatment, will be included in the cross-over study.
•Of note, for SRF on OCT does not have to involve the fovea for patients to be included in the cross-over study.
•In the Long-term follow-up study, the following patients will be included:
•- Subjects who do not show any SRF on OCT at final visit of the PLACE trial will be included.
•Of note, patients who were not initially included in the long-term follow-up study, because of persistent SRF on OCT, were automatically included in the cross-over study.

发起方